Tonix Pharma (TNXP) has submitted an NDA for its candidate TNX-102 SL for fibromyalgia, with a PDUFA date set for August 15, 2025. See why I'm on the sidelines.
Shift4 Payments' Q4 2024 earnings showed strong growth in e2e payment volume and significant increases in net income. Read ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback